Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that Professor KJ Patel has been appointed as the new Director of the MRC Weatherall Institute of Molecular Medicine and the MRC Molecular Haematology Unit at the University of Oxford.

Professor KJ Patel

Professor KJ Patel FRS FMedSci will start full-time as Director of the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU) from 1st June 2020. Between 1st April to 31st May, Professor Patel will be managing these two roles on a part-time basis, whilst transitioning his research programme from the MRC Laboratory of Molecular Biology in Cambridge (MRC LMB), where he is currently based.

Professor Hugh Watkins, Head of the Radcliffe Department of Medicine, said “I am delighted to welcome KJ to the department and am excited about his vision for the MRC MHU and the MRC WIMM. KJ is a scientist of the highest distinction whose own work epitomises how fundamental molecular insights drive important medical advances.”

Read more on the MRC WIMM website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.